![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yoshimoto T. Naruse M. Irie K. Tanabe A. Seki T. Tanaka M. Imaki T. Naruse K. Muraki T. Matsuda Y. Demura H.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.351, Iss.1, 1998-06, pp. : 61-66
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Orallo F. Garcia-Ferreiro T. Enguix M.J. Tristan H. Masaguer C. Ravina E. Cadavid I. Loza M.I.
General Pharmacology, Vol. 40, Iss. 2, 2003-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Natriuretic peptides as therapeutic targets
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Natriuretic Peptides: Future Use?
Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. :